The Academy of Scientific Research and Technology (ASRT) announced on Saturday, that Egypt was selected as the headquarters of the Regional Center for Raising Bio-Manufacturing Capacities for the North African Region (RCCN) in partnership with Morocco.
In this context, the Minister of Higher Education and Scientific Research, Ayman Ashour, stressed that the success of the Egyptian file reflects the Egyptian state’s commitment to developing the pharmaceutical manufacturing sector, especially in the field of vaccines, and enhancing scientific research in the field of biotechnology.
He added that this achievement comes within Egypt’s strategy to enhance health security, not only locally, but also on the African continent, in line with the state’s vision of localizing the vaccine industry and achieving self-sufficiency in it.
The announcement of this achievement came on the sidelines of the Second Forum on Vaccine and Health Products Manufacturing for African Union Member States, organized by the Africa Centers for Disease Control and Prevention, in collaboration with the Global Vaccine Alliance (Gavi) and the Regional Vaccine Manufacturing Center (RVMC), and hosted by the Egyptian Unified Procurement Authority in Cairo during the period from 4 to 6 February 2025.
The Egyptian Vaccine Manufacturers Alliance (EVMA) includes six main entities, namely the Egyptian Unified Procurement Authority, the Academy of Scientific Research and Technology, the Egyptian Drug Authority, the Faculty of Pharmacy – Ain Shams University, and the Faculty of Pharmacy – Cairo University, in addition to the alliance’s member manufacturers, namely Vacsera, Biogeneric Pharma, the Egyptian Vaccine City, Genvax, and Eva Pharma.
The alliance submitted this file within the framework of the strategy to raise local and regional capacities to develop the workforce in the field of biomanufacturing, and to enhance industrial integration among African countries in this vital field.
The Ministry of Higher Education said in a statement that Egypt’s success in hosting the regional center to raise vital manufacturing capacities for North Africa is a pivotal step towards achieving self-sufficiency in vaccines and enhancing vital manufacturing capacities on the continent.
